Literature DB >> 8748219

Fatty-acid peroxidation in relation to trace elements in serum of patients with homozygous sickle-cell anemia and beta-thalassemia: a gas-chromatographic study.

E A Preoteasa1, I Ionescu.   

Abstract

Due mainly to a deeply disturbed iron metabolism, intense production of oxygen-derived free radicals occurs in genetic hemoglobinopathies such as homozygous sickle-cell anemia and beta-thalassemia. Together with impairments in the natural factors involved in oxy-radical detoxication, this results in intense oxidative stress leading to lipid peroxidation in the blood components. In search of peroxidation effects, we undertook a gas chromatographic study of both the total and phospholipid-bound fatty acids in the serum from sickle-cell disease and beta-thalassemia patients. Specific alterations of pathologic origin have been evidenced in the profiles of total and phospholipidic fatty acids, as well as in the elongation-desaturation ratios of the total fatty acids. Results are consistent with lipid peroxidations and fatty-acid biosynthesis disturbances in both diseases, but more severe in thalassemia than in sickle-cell anemia. Increased serum selenium in the latter disease might exert a protective action against lipid peroxidation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8748219

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  3 in total

1.  Pro-oxidant and anti-oxidant status in patients of sickle cell anaemia.

Authors:  Jyoti Titus; Suresh Chari; Madhur Gupta; Nitin Parekh
Journal:  Indian J Clin Biochem       Date:  2004-07

2.  Comparative analysis of RBC membrane fatty acids, proteins and glycophorin in patients with heterozygous beta thalassemia and iron deficiency anemia.

Authors:  S P Sanghani; V A Haldankar
Journal:  Indian J Clin Biochem       Date:  2006-09

3.  Alterations in serum levels of copper, zinc, and selenium among children with sickle cell anemia

Authors:  Rana Hasanato
Journal:  Turk J Med Sci       Date:  2019-10-24       Impact factor: 0.973

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.